Ocrelizumab: A New Therapeutic Paradigm for Multiple Sclerosis

被引：2

作者：

Chin, Peter ^{[1
]}

Chan, Andrew C. ^{[2
]}

机构：

[1] Genentech Inc, Med Affairs, One DNA Way, San Francisco, CA 94080 USA

[2] Genentech Inc, Res, One DNA Way, San Francisco, CA 94080 USA

来源：

BIOCHEMISTRY | 2018年 / 57卷 / 05期

关键词：

RITUXIMAB; PLACEBO;

D O I：

10.1021/acs.biochem.7b00796

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：474 / 476

页数：3

共 5 条

[1] Immunopathology of multiple sclerosis [J].

Dendrou, Calliope A. ;

Fugger, Lars ;

Friese, Manuel A. .

NATURE REVIEWS IMMUNOLOGY, 2015, 15 (09) :545-558

[2] Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis [J].

Hauser, S. L. ;

Bar-Or, A. ;

Comi, G. ;

Giovannoni, G. ;

Hartung, H. -P. ;

Hemmer, B. ;

Lublin, F. ;

Montalban, X. ;

Rammohan, K. W. ;

Selmaj, K. ;

Traboulsee, A. ;

Wolinsky, J. S. ;

Arnold, D. L. ;

Klingelschmitt, G. ;

Masterman, D. ;

Fontoura, P. ;

Belachew, S. ;

Chin, P. ;

Mairon, N. ;

Garren, H. ;

Kappos, L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (03) :221-234

[3] B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis [J].

Hauser, Stephen L. ;

Waubant, Emmanuelle ;

Arnold, Douglas L. ;

Vollmer, Timothy ;

Antel, Jack ;

Fox, Robert J. ;

Bar-Or, Amit ;

Panzara, Michael ;

Sarkar, Neena ;

Agarwal, Sunil ;

Langer-Gould, Annette ;

Smith, Craig H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (07) :676-688

[4] Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial [J].

Hawker, Kathleen ;

O'Connor, Paul ;

Freedman, Mark S. ;

Calabresi, Peter A. ;

Antel, Jack ;

Simon, Jack ;

Hauser, Stephen ;

Waubant, Emmanuelle ;

Vollmer, Timothy ;

Panitch, Hillel ;

Zhang, Jiameng ;

Chin, Peter ;

Smith, Craig H. .

ANNALS OF NEUROLOGY, 2009, 66 (04) :460-471

[5] Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis [J].